Morgan Stanley Helius Medical Technologies, Inc. Transaction History

Morgan Stanley

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.23 - $0.41 $0 - $0	-2 Reduced 0.94%	211 $0
Q4 2022 Feb 14, 2023	SELL	$0.22 - $14.5 $1,604 - $105,719	-7,291 Reduced 97.16%	213 $0
Q3 2022 Nov 14, 2022	BUY	$0.36 - $17.1 $2,623 - $124,624	7,288 Added 3374.07%	7,504 $2,000
Q2 2022 Oct 27, 2022	SELL	$1.14 - $3.48 $255 - $779	-224 Reduced 50.91%	216 $0
Q2 2022 Aug 15, 2022	SELL	$1.14 - $3.48 $255 - $779	-224 Reduced 50.91%	216 $0
Q1 2022 Oct 27, 2022	BUY	$3.07 - $5.55 $687 - $1,243	224 Added 103.7%	440 $2,000
Q1 2022 May 13, 2022	BUY	$3.07 - $5.55 $1,350 - $2,442	440 New	440 $2,000

Ticker HSDT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 28,197,200
Market Cap $12.7M
Description
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gai...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.